CN102266541A - Chinese medicinal plaster for treating hyperosteogeny or hyperosteogeny pain - Google Patents
Chinese medicinal plaster for treating hyperosteogeny or hyperosteogeny pain Download PDFInfo
- Publication number
- CN102266541A CN102266541A CN2011101918905A CN201110191890A CN102266541A CN 102266541 A CN102266541 A CN 102266541A CN 2011101918905 A CN2011101918905 A CN 2011101918905A CN 201110191890 A CN201110191890 A CN 201110191890A CN 102266541 A CN102266541 A CN 102266541A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- hyperosteogeny
- pain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a Chinese medicinal composition for treating hyperosteogeny or hyperosteogeny pain and a preparation method thereof. The Chinese medicinal composition comprises the following components in part by weight: 10 to 30 parts of parsnip, 10 to 30 parts of borneol, 10 to 30 parts of incised notopterygium rhizome, 10 to 30 parts of Szechuan lovage rhizome, 5 to 15 parts of asarum, 3 to 6 parts of common monkshood mother root, 3 to 6 parts of kusnezoff monkshood root, 10 to 30 parts of clematis root, 10 to 30 parts of obscured homalomena rhizome, 10 to 30 parts of kudzuvine root, 5 to 15 parts of angelica dahurica, 10 to 30 parts of garden balsam stem, 10 to 30 parts of frankincense, 10 to 30 parts of myrrh, 5 to 15 parts of dragon's blood, and 5 to 15 parts of dried ginger. By using the action mechanism that the internal diseases are treated externally, the Chinese medicinal composition is realized on the aspects of meridian conduction, skin penetration and mucosa absorption. The Chinese medicinal composition provided by the invention is Chinese medicinal plaster for treating hyperosteogeny or hyperosteogeny pain with the advantages of good curative effect, low cost, no side effect and short treatment course.
Description
Technical field:
The invention belongs to tcm field, specifically relate to a kind of Chinese medicine plaster for the treatment of hyperosteogeny or osteoproliferation pain.
Background technology:
Hyperosteogeny claims hypertrophy disease, hypertrophy or degenerative osteoarthritis again.Good sending out located in cervical vertebra, lumbar vertebra, hip, knee joint, root bone etc., but single-shot or pilosity.Be common ailment of middle-aged and old, frequently-occurring disease.Due to the loss of deficiency of the liver and kindey, essence and blood is arranged more for the paathogenic factor of primary disease or wind-cold damp pathogen is taken advantage of a weak point, the resistance of QI and blood numbness, muscles and bones mistake support.Because of the local excitation affected part tendon anxiety of the sclerotin of hypertrophy, peripheral nerve pressurized, so symptoms such as affected part pain, function limitations.The X line is penetrated sheet and is checked that osteoarthrosis is hypertrophy or degenerative change.The treatment primary disease adopts massage to come methods such as relief of symptoms or physical therapy, also useful medicine person more at present.But since to the patient cause painful too many, and effect is also undesirable, massages and also loses time, and some medicine for external use are also arranged, but have mostly that effect is undesirable, delay treatment, problem such as cost is also high, the course of treatment is long, produce effects slowly.
The Chinese patent literature of application publication number CN 101874892A (application number 200910115268.9) provides a kind of hyperosteogeny that is used for the treatment of, the health care external medicinal liquid that lumbar disc is outstanding, and by Radix Clematidis, Pollen Typhae, Folium Artemisiae Argyi, the Radix Aucklandiae, Cortex erythrinae, Squama Manis, Scorpio, joy clam, Herba speranskiae tuberculatae, Ramulus Cinnamomi, Rhizoma Polygoni Cuspidati, Flos Carthami, Radix Aconiti, Radix Aconiti Kusnezoffii, Eupolyphaga Seu Steleophaga, Herba Asari, Pericarpium Zanthoxyli, Semen Ricini, the Radix Angelicae Dahuricae, Flos Caryophylli, Squama Manis, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, Radix Angelicae Sinensis, Fructus Perillae, Radix Cyathulae, CHUANSHAO, Radix Paeoniae Rubra, Rhizoma Corydalis, Radix Notoginseng, the Rhizoma Pinelliae, Semen Strychni, Radix Salviae Miltiorrhizae, Fructus Chaenomelis, Radix Saposhnikoviae, Rhizoma Zingiberis, Cortex Cinnamomi, Radix Aconiti Lateralis Preparata, Fructus Evodiae, Rhizoma Alpiniae Officinarum, Fructus Piperis, anistree mattress perfume (or spice), Sanguis Draxonis, Rhizoma Arisaematis, Herba Ephedrae, Borneolum Syntheticum, road perfume (or spice), Lignum Pini Nodi, Camphora is given birth to the mountain quarrel, and 51 flavor Chinese medicines such as WAGNWEIZI are made.The Chinese patent literature of Granted publication CN 100425265C (application number 200610105028.7) provides a kind of a kind of Chinese medicine composition that can effectively treat hyperosteogeny that the invention provides, and this medicine is to be made by crude drug such as Radix Angelicae Sinensis, Rhizoma Et Radix Notopterygii, punt-pole basis, Radix Aconiti, Radix Aconiti Lateralis Preparata, CHUANSHAO, Radix Paeoniae Rubra, Flos Carthami, Pheretima, Sanguis Draxonis, first Pu, Medulla Junci, Herba Asari, Ramulus Cinnamomi, Radix Salviae Miltiorrhizae, Radix Saposhnikoviae, Semen Raphani, Semen Sinapis Albae, Radix Clematidis, Olibanum, Myrrha, stockaded village's perfume (or spice), Borneolum Syntheticums.
Prior art exist easily cause untoward reaction, be difficult for accurate consumption, prescription dosage form shortcoming such as science not.
Summary of the invention:
At the deficiencies in the prior art, the invention provides that a kind of therapeutic effect is good, cost is low, have no side effect, the treatment hyperosteogeny of short treating period or the Chinese medicine plaster of osteoproliferation pain.
The present invention is achieved by the following technical solutions:
A kind of Chinese medicine plaster for the treatment of hyperosteogeny or osteoproliferation pain is to be made by the raw material of following weight portion: Radix Saposhnikoviae 10-30 part, Borneolum Syntheticum 10-30 part, Rhizoma Et Radix Notopterygii 10-30 part, Rhizoma Chuanxiong 10-30 part (preferred 15-25 part), Herba Asari 5-15 part, Radix Aconiti 3-6 part, Radix Aconiti Kusnezoffii 3-6 part, Radix Clematidis 10-30 part, Rhizoma Homalomenae 10-30 part, Radix Puerariae 10-30 part, Radix Angelicae Dahuricae 5-15 part, Herba speranskiae tuberculatae 10-30 part, Olibanum 10-30 part, Myrrha 10-30 part (preferred 15-22 part), Sanguis Draxonis 5-15 part, Rhizoma Zingiberis 5-15 part.
Described Chinese medicine plaster, preferred scheme is, is to be made by the raw material of following weight portion: Radix Saposhnikoviae 12-25 part, Borneolum Syntheticum 15-25 part, Rhizoma Et Radix Notopterygii 15-25 part, Rhizoma Chuanxiong 12-25 part, Herba Asari 8-12 part, Radix Aconiti 3.5-5 part, Radix Aconiti Kusnezoffii 3.5-5 part, Radix Clematidis 12-25 part, Rhizoma Homalomenae 15-25 part, Radix Puerariae 12-25 part, Radix Angelicae Dahuricae 8-12 part, Herba speranskiae tuberculatae 12-28 part, Olibanum 12-28 part, Myrrha 12-28 part, Sanguis Draxonis 8-12 part, Rhizoma Zingiberis 8-12 part.
Described Chinese medicine plaster, preferred scheme is, is to be made by the raw material of following weight portion: Radix Saposhnikoviae 18-22 part, Borneolum Syntheticum 15-22 part, Rhizoma Et Radix Notopterygii 15-22 part, Rhizoma Chuanxiong 18-22 part, Herba Asari 9-11 part, Radix Aconiti 4-5 part, Radix Aconiti Kusnezoffii 4-5 part, Radix Clematidis 15-22 part, Rhizoma Homalomenae 18-22 part, Radix Puerariae 14-22 part, Radix Angelicae Dahuricae 9-11 part, Herba speranskiae tuberculatae 15-25 part, Olibanum 15-25 part, Myrrha 15-25 part, Sanguis Draxonis 9-11 part, Rhizoma Zingiberis 9-11 part.
Described Chinese medicine plaster, preferred scheme is that the parts by weight of described each component are: 20 parts of Radix Saposhnikoviaes, 20 parts of Borneolum Syntheticums, 20 parts of Rhizoma Et Radix Notopterygiis, 20 parts of Rhizoma Chuanxiongs, 10 parts of Herba Asaris, 4.5 parts of Radix Aconitis, 4.5 parts of Radix Aconiti Kusnezoffii, 20 parts of Radix Clematidis, 20 parts of Rhizoma Homalomenaes, 20 parts of Radix Puerariaes, 10 parts of the Radixs Angelicae Dahuricae, 20 parts of Herba speranskiae tuberculataes, 20 parts of Olibanums, 20 parts of Myrrhas, 10 parts of Sanguis Draxonis, 10 parts of Rhizoma Zingiberiss.
The pharmacology of each component of the present invention and mechanism of action: Radix Saposhnikoviae: removing dampness to relieve pain; Be used for anemofrigid-damp arthralgia spasm of muscles and vessels, arthrodynia of extremities.The moderate refrigeration function is arranged, and can remove vasospasm pain.Rhizoma Et Radix Notopterygii: numbness relieving and pain relieving is used for rheumatism numbness pain, the cold expelling effect is stronger, and the antiinflammation of expelling cold and relieving exterior syndrome non-steroidal is arranged.Rhizoma Chuanxiong: blood-activating and qi-promoting, wind-expelling pain-stopping, Rhizoma Chuanxiong contain a kind of oily alkaloid, ferulic acid volatilization wet goods can be benumbed nerve centre, so analgesia spasmolytic sedation is arranged, the effect that also has vitamin antagonist E to lack is so can soften outgrowth sclerotin.Herba Asari: expelling cold and relieving exterior syndrome, the local paralysis effect is arranged, increase the permeability of blood capillary, be a kind of skin penetrant commonly used.Radix Aconiti, Radix Aconiti Kusnezoffii: the ailment said due to cold or exposure that can be dispersed in table, cold-damp by the lining, be used to control wind and cold numbness pain numbness, though this 2 flavor medicine has certain toxicity, but it is very little to be used in external drug intoxication, under half situation of general consumption, almost non-toxic property is only made neck through medicinal or increase the permeability of medicine to skin.Radix Clematidis: expelling wind and removing dampness, removing obstruction in the collateral to relieve pain; Be used for rheumatic arthralgia, ailment said due to cold or exposure wins partially, Ju Luan System pain, should with other blood circulation promoting medicines with using.Expectorant is the reason as disappear insubstantial phlegm and phlegm stagnating in meridian in this side by drink, the dredge the meridian passage effect.Radix Clematidis: hot loosing is apt to away, tonneau warm in nature 12 warps that can pass through.Can drive at the wind of table and can change the wetting in the lining again, stimulating the menstrual flow reaches network, can lead the key medicine that can declare to gout.Rhizoma Homalomenae: the wind-damp dispelling bone and muscle strengthening is used for rheumatism and arthritis, bones and muscles pain, contracture numbness.Radix Puerariae: expelling pathogenic factors from muscles for reducing heat, yang invigorating, remove local muscle spasm, the congestion of blood vessel of contrafluxion is alleviated, promoting yang-energy increases blood circulation, and the heresy of the cold-damp of stasis of blood resistance is dispeled, and alleviates local excitation and water and applies the local inflammation that can disappear.The Radix Angelicae Dahuricae: the pain relieving of cold expelling wind dispelling, the removing dampness detumescence has analgesia and excited central action.Herba speranskiae tuberculatae: expelling wind and dampness, be used for new and old rheumatism bones and muscles pain promoting blood circulation and stopping pain, the softening the hard mass painful abdominal mass that disappears makes the osteomalacia of hypertrophy.Olibanum: promoting blood circulation and stopping pain, it is active to be used for swelling and pain due to blood stasis, the contracture of muscle arteries and veins, secondary muscle, is used for the muscle arteries and veins contracture of numbness cellulitis; It is logical that the Olibanum hardship is let out the hot temperature of loosing, thus can declare logical muscle arteries and veins, the activation stagnation resolvation of subsiding a swelling, blood then pain alive only, clonic spasm of the muscle stretches, swell and ache disappear, muscle is long, so there is pain relieving to stretch the merit of muscle detumescence and promoting granulation.Myrrha: the promoting blood circulation and stopping pain detumescence, Olibanum and Myrrha all are purpose with the eliminating stasis to stop pain, because of the two gas perfume (or spice), perfume (or spice) can be walked to scurry and the row that looses, so energy promoting the circulation of blood dissipating blood stasis promoting the circulation of QI collateral dredging, blood circulation of qi promoting profit then pain is the special medicine of pain relieving from ending.The disease of stagnation of QI sharp ache, the same usefulness of two medicines, benefit increase its promoting blood circulation and stopping pain effect.The hot Wen Xiangrun of Olibanum only, can walk that gas in the blood holds concurrently can relaxing muscles and tendons and activating QI and blood in the collateral, and the master of Myrrha and Olibanum are similar, but that its hardship is let out power is strong, and the clots absorbing blood that looses is solely arrogated to oneself its length.Just because of an offset gas, an inclined to one side clots absorbing is so the two 5 application mutually of the pain of coagulation of QI-blood are got and knowingly followed the example of a wrongdoer victory.The power of walking to scurry because of Olibanum fragrance is stronger, and the permeability that increases skin so can be good at passing the skin peptide so also be a kind of advantages of good skin penetrating agent, make medicine enter intralesional easily and works.Sanguis Draxonis: the clots absorbing pain relieving, be used for the swelling and pain due to blood stasis of tendon breaking fracture, the stagnation resolvation of remollescent bony spur is removed, the newborn congestion that normal structure produced swells and ache and is dissipated.Rhizoma Zingiberis: the warming middle-JIAO recuperating depleted YANG, make the sufficient and cloudy gas of yang-energy from disappearing, Rhizoma Zingiberis can make the blood capillary diastole, strengthens the permeability of skin peptide, and medicine is seen through skin short saturating effect.Borneolum Syntheticum: the stagnated fire of loosing, logical all keys are a kind of skin penetration enhancer commonly used.All medicine adapteds complement each other, play altogether blood-activating and qi-promoting, eliminating stasis to stop pain, muscle relaxing collaterals activating, the pain relieving of collateral dredging clots absorbing, by the wet softening bony spur of interior cold, thereby make the bony spur of hypertrophy softening, pain relief.
The preparation method of Chinese medicine plaster of the present invention, getting each raw material pulverizing is that powdery is crossed 200 mesh sieves, makes medicated powder, and medicated powder with mature vinegar furnishing pasty state ointment, is applied on the two-layer nonwoven, spreads on the affected part outward, state of an illness the lighter 2-3 course of treatment, symptom can obviously alleviate; State of an illness weight person transference cure 5-6 the course of treatment.Force on each course of treatment 5, change dressings cream every other day once, therapeutic effect is good, and overall efficiency is more than 95%.The used total mechanism of action of the present invention is: use the mechanism of action of traditional Chinese medical science inner disease outer treat, now from meridians conduction, skin penetrate, the mucosa absorption each side realizes.
The specific embodiment:
Describe the solution of the present invention in detail below in conjunction with embodiment, but protection domain is not by this restriction.
Embodiment 1: prepare a kind of Chinese medicine plaster (every part of 10g) for the treatment of hyperosteogeny or osteoproliferation pain:
Get 10 parts of Radix Saposhnikoviaes, 10 parts of Borneolum Syntheticums, 10 portions of Rhizoma Et Radix Notopterygiis, 10 parts of rivers, 5 parts of Herba Asaris, 3 portions of Radix Aconitis, 3 portions of Radix Aconiti Kusnezoffii, 10 parts of Radix Clematidis, 10 parts of Rhizoma Homalomenaes, 10 parts of Radix Puerariaes, 5 parts of Radixs Angelicae Dahuricae, 10 parts of Herba speranskiae tuberculataes, 10 parts of Olibanums, 10 Myrrhas, 5 parts of Sanguis Draxonis, 5 portions of Rhizoma Zingiberiss, pulverizing is crossed 200 mesh sieves for powdery, during making medicamental pulverata is applied on the two-layer nonwoven with mature vinegar furnishing pasty state plaster, spread on the affected part outward, each component all by weight.
Embodiment 2: prepare a kind of Chinese medicine plaster (every part of 15g) for the treatment of hyperosteogeny or osteoproliferation pain
Get 30 parts of Radix Saposhnikoviaes, 30 parts of Borneolum Syntheticums, 30 portions of Rhizoma Et Radix Notopterygiis, 30 parts of rivers, 15 parts of Herba Asaris, 6 portions of Radix Aconitis, 6 portions of Radix Aconiti Kusnezoffii, 30 parts of Radix Clematidis, 30 parts of Rhizoma Homalomenaes, 30 parts of Radix Puerariaes, 15 parts of Radixs Angelicae Dahuricae, 30 parts of Herba speranskiae tuberculataes, 30 parts of Olibanums, 30 Myrrhas, 15 parts of Sanguis Draxonis, 15 portions of Rhizoma Zingiberiss, pulverizing is crossed 200 mesh sieves for powdery, during making medicamental pulverata is applied on the two-layer nonwoven with mature vinegar furnishing pasty state plaster, spread on the affected part outward, each component all by weight.
Embodiment 3: prepare a kind of Chinese medicine plaster (every part of 20g) for the treatment of hyperosteogeny or osteoproliferation pain
Get 20 parts of Radix Saposhnikoviaes, 20 parts of Borneolum Syntheticums, 20 portions of Rhizoma Et Radix Notopterygiis, 20 parts of rivers, 10 parts of Herba Asaris, 4.5 portions of Radix Aconitis, 4.5 portions of Radix Aconiti Kusnezoffii, 20 parts of Radix Clematidis, 20 parts of Rhizoma Homalomenaes, 20 parts of Radix Puerariaes, 10 parts of Radixs Angelicae Dahuricae, 20 parts of Herba speranskiae tuberculataes, 20 parts of Olibanums, 20 Myrrhas, 10 parts of Sanguis Draxonis, 10 portions of Rhizoma Zingiberiss, pulverizing is crossed 200 mesh sieves for powdery, during making medicamental pulverata is applied on the two-layer nonwoven with mature vinegar furnishing pasty state plaster, spread on the affected part outward, each component all by weight.
Utilize the model case of Chinese medicine composition in clinical practice of the embodiment of the invention 3 gained treatment dysmenorrhea:
Model case 1 turns round and look at certain, woman, 57 years old, retired worker.Rigidity of the neck, easy stiff neck, surplus year in year out nearly half a year, right arm was numb.Sense of heaviness is arranged, and left hand held object is unable, and is unable when head is changed one's position.Thready and stringy pulse, white and thin fur, cervical vertebra film making shows: C5,6,7 physiologic radians become straight, gap and slightly narrow down, and the C5C6 trailing edge is seen lip sample hyperosteogeny, traction therapeutic once, poor effect.Advise and use the present invention, be clearly better with back first quarter moon stiffness of the neck, the arm picotement alleviates, logotype 1 month, and all symptoms all disappear, and follow up a case by regular visits to not recurrence in 1 year.
Model case 2: stone, woman, 40 years old.Double knee joint pain is surplus October, influences stride, once penetrates the sheet inspection and is diagnosed as the bilateral knee hyperosteogeny.Arthroncus, the state of an illness increased the weight of when year was met Changes in weather.After advising disease application the present invention to treat for 2 weeks, subjective symptoms obviously alleviates, and the stride phenomenon takes a turn for the better when walking, and arthroncus also alleviates, and continues medication 20 days, and above-mentioned symptom disappears.Following up a case by regular visits to a year and a half does not recur.
Model case 3: Chen, man, 30 years old, driver.Lumbago is surplus half a year, by suffer from cold and impairment caused by overstrain after cause that its disease is acute with the right side, changing one's position, it is unfavorable to face upward the mansion.Once Western medicine diagnose was a lumbar muscle strain, lumbar vertebra 4,5 slight hypertrophy, and stomach discomfort behind the medicine requires external treatment, gives the present invention, and 5 days low back alleviation of pain of medication are light, and first quarter moon is promptly healed, and recurs after half a year, continues surplus the present invention 10 day promptly to heal.With not recurrence in anti-15 months.
Model case 4: the week certain, man, 50 years old, cadre.Lumbago 1 year is surplus,, moves down to buttocks and thigh gradually for very with the left side, is diagnosed as hyperosteogeny, sciatica through the orthopaedics inspection, and advise with the present invention 10 surplus subsides because of cold type of pain influence sleep night, and not recurrence in 18 months is followed up a case by regular visits in state of an illness recovery from illness.
In addition, the technology of the present invention effect also can illustrate by clinical effectiveness.
Clinical data: in May, 2008-2010 year March is totally 50 routine hyperosteogeny patients or with pain, uses 40 years old mean age of age 20-60 of the present invention year, and ailing 15 years to 1 year, sex male was more than the women.Be divided into of the present invention group and to matched group, matched group is taken resisting hyperosteogeny medicine and pain medicine, externally applied plaster.Two groups are not had significant difference at aspects such as age, sex, the state of an illness, course of disease length, have comparability.Physical resource sees Table one.
Table one
Therapeutic effect: 50 examples of curing the disease, effective 49 examples, invalid 1 example, total effective rate 98%.Effect is better than matched group, during the treatment except that two examples to the non-woven fabrics allergy, do not have irritated phenomenon in 2 days through stopping using, do not have other untoward reaction.
Claims (5)
1. Chinese medicine plaster for the treatment of hyperosteogeny or osteoproliferation pain, it is characterized in that, be to be made by the raw material of following weight portion: Radix Saposhnikoviae 10-30 part, Borneolum Syntheticum 10-30 part, Rhizoma Et Radix Notopterygii 10-30 part, Rhizoma Chuanxiong 10-30 part, Herba Asari 5-15 part, Radix Aconiti 3-6 part, Radix Aconiti Kusnezoffii 3-6 part, Radix Clematidis 10-30 part, Rhizoma Homalomenae 10-30 part, Radix Puerariae 10-30 part, Radix Angelicae Dahuricae 5-15 part, Herba speranskiae tuberculatae 10-30 part, Olibanum 10-30 part, Myrrha 10-30 part, Sanguis Draxonis 5-15 part, Rhizoma Zingiberis 5-15 part.
2. Chinese medicine plaster according to claim 1, it is characterized in that, be to be made by the raw material of following weight portion: Radix Saposhnikoviae 12-25 part, Borneolum Syntheticum 15-25 part, Rhizoma Et Radix Notopterygii 15-25 part, Rhizoma Chuanxiong 12-25 part, Herba Asari 8-12 part, Radix Aconiti 3.5-5 part, Radix Aconiti Kusnezoffii 3.5-5 part, Radix Clematidis 12-25 part, Rhizoma Homalomenae 15-25 part, Radix Puerariae 12-25 part, Radix Angelicae Dahuricae 8-12 part, Herba speranskiae tuberculatae 12-28 part, Olibanum 12-28 part, Myrrha 12-28 part, Sanguis Draxonis 8-12 part, Rhizoma Zingiberis 8-12 part.
3. Chinese medicine plaster according to claim 2, it is characterized in that, be to be made by the raw material of following weight portion: Radix Saposhnikoviae 18-22 part, Borneolum Syntheticum 15-22 part, Rhizoma Et Radix Notopterygii 15-22 part, Rhizoma Chuanxiong 18-22 part, Herba Asari 9-11 part, Radix Aconiti 4-5 part, Radix Aconiti Kusnezoffii 4-5 part, Radix Clematidis 15-22 part, 1822 parts of Rhizoma Homalomenaes, Radix Puerariae 14-22 part, Radix Angelicae Dahuricae 9-11 part, Herba speranskiae tuberculatae 15-25 part, Olibanum 15-25 part, Myrrha 15-25 part, Sanguis Draxonis 9-11 part, Rhizoma Zingiberis 9-11 part.
4. Chinese medicine plaster according to claim 3, it is characterized in that the parts by weight of described each component are: 20 parts of Radix Saposhnikoviaes, 20 parts of Borneolum Syntheticums, 20 parts of Rhizoma Et Radix Notopterygiis, 20 parts of Rhizoma Chuanxiongs, 10 parts of Herba Asaris, 4.5 parts of Radix Aconitis, 4.5 parts of Radix Aconiti Kusnezoffii, 20 parts of Radix Clematidis, 20 parts of Rhizoma Homalomenaes, 20 parts of Radix Puerariaes, 10 parts of the Radixs Angelicae Dahuricae, 20 parts of Herba speranskiae tuberculataes, 20 parts of Olibanums, 20 parts of Myrrhas, 10 parts of Sanguis Draxonis, 10 parts of Rhizoma Zingiberiss.
5. according to the preparation method of the arbitrary described Chinese medicine plaster of claim 1-4, it is characterized in that getting each raw material pulverizing is that powdery is crossed 200 mesh sieves, makes medicated powder, with medicated powder mature vinegar furnishing pasty state ointment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110191890 CN102266541B (en) | 2011-07-11 | 2011-07-11 | Chinese medicinal plaster for treating hyperosteogeny or hyperosteogeny pain |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110191890 CN102266541B (en) | 2011-07-11 | 2011-07-11 | Chinese medicinal plaster for treating hyperosteogeny or hyperosteogeny pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102266541A true CN102266541A (en) | 2011-12-07 |
| CN102266541B CN102266541B (en) | 2012-12-26 |
Family
ID=45049121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110191890 Expired - Fee Related CN102266541B (en) | 2011-07-11 | 2011-07-11 | Chinese medicinal plaster for treating hyperosteogeny or hyperosteogeny pain |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102266541B (en) |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103055265A (en) * | 2013-01-15 | 2013-04-24 | 丁文田 | Pain-relieving medicine patch |
| CN103372065A (en) * | 2012-04-19 | 2013-10-30 | 阎小萍 | External traditional Chinese medicine for treating arthritis and preparation method thereof |
| CN103385944A (en) * | 2013-07-31 | 2013-11-13 | 钱家美 | Formula for osteoproliferation and application method thereof |
| CN104873699A (en) * | 2015-06-03 | 2015-09-02 | 刘智博 | Traditional Chinese medicine ointment and preparation method thereof |
| CN105998566A (en) * | 2015-10-12 | 2016-10-12 | 烟台市蓝洋之草医药生物科技有限公司 | Method for preparing traditional Chinese preparation for treating osteoproliferation |
| CN106177849A (en) * | 2016-08-16 | 2016-12-07 | 王信东 | A kind of Chinese medicine composition treating osteoarthritis, neck prolapse of lumbar intervertebral disc and preparation method thereof |
| CN106421248A (en) * | 2016-10-21 | 2017-02-22 | 刘玉杰 | Traditional Chinese medicine plaster for treating hyperostosis |
| CN108969607A (en) * | 2017-06-02 | 2018-12-11 | 徐定清 | A kind of pain in the loins application spirit |
| CN109260343A (en) * | 2018-11-06 | 2019-01-25 | 吴丽娟 | A kind of drug and preparation method thereof for treating osteoproliferation |
| CN109646806A (en) * | 2018-12-17 | 2019-04-19 | 南京日光生物科技有限公司 | A kind of backbone patch and preparation method thereof with far infrared heating layer |
| CN110038077A (en) * | 2019-05-31 | 2019-07-23 | 王亮 | A kind of plaster for treating osteoproliferation, spur |
| CN110882373A (en) * | 2019-12-10 | 2020-03-17 | 刘维来 | A Chinese medicinal preparation for external use for treating various osteopathia |
| CN112168684A (en) * | 2020-10-28 | 2021-01-05 | 王秀琴 | Moxa cone for treating cyst, nodule, hyperplasia and tumor and preparation method thereof |
| CN112603957A (en) * | 2021-01-11 | 2021-04-06 | 谭秀波 | Traditional Chinese medicine for treating hyperosteogeny and preparation method thereof |
| CN114272226A (en) * | 2021-12-29 | 2022-04-05 | 贵州德良方药业股份有限公司 | External plaster for treating hyperosteogeny and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1745801A (en) * | 2004-09-10 | 2006-03-15 | 崔高远 | Ointment for treating spur |
| CN1814247A (en) * | 2005-11-22 | 2006-08-09 | 田茂宁 | Chinese medicine bone-setting ointment and preparing method |
-
2011
- 2011-07-11 CN CN 201110191890 patent/CN102266541B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1745801A (en) * | 2004-09-10 | 2006-03-15 | 崔高远 | Ointment for treating spur |
| CN1814247A (en) * | 2005-11-22 | 2006-08-09 | 田茂宁 | Chinese medicine bone-setting ointment and preparing method |
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103372065A (en) * | 2012-04-19 | 2013-10-30 | 阎小萍 | External traditional Chinese medicine for treating arthritis and preparation method thereof |
| CN103372065B (en) * | 2012-04-19 | 2015-04-15 | 阎小萍 | External traditional Chinese medicine for treating arthritis and preparation method thereof |
| CN103055265A (en) * | 2013-01-15 | 2013-04-24 | 丁文田 | Pain-relieving medicine patch |
| CN103385944A (en) * | 2013-07-31 | 2013-11-13 | 钱家美 | Formula for osteoproliferation and application method thereof |
| CN104873699A (en) * | 2015-06-03 | 2015-09-02 | 刘智博 | Traditional Chinese medicine ointment and preparation method thereof |
| CN105998566A (en) * | 2015-10-12 | 2016-10-12 | 烟台市蓝洋之草医药生物科技有限公司 | Method for preparing traditional Chinese preparation for treating osteoproliferation |
| CN106177849A (en) * | 2016-08-16 | 2016-12-07 | 王信东 | A kind of Chinese medicine composition treating osteoarthritis, neck prolapse of lumbar intervertebral disc and preparation method thereof |
| CN106421248A (en) * | 2016-10-21 | 2017-02-22 | 刘玉杰 | Traditional Chinese medicine plaster for treating hyperostosis |
| CN108969607A (en) * | 2017-06-02 | 2018-12-11 | 徐定清 | A kind of pain in the loins application spirit |
| CN109260343A (en) * | 2018-11-06 | 2019-01-25 | 吴丽娟 | A kind of drug and preparation method thereof for treating osteoproliferation |
| CN109646806A (en) * | 2018-12-17 | 2019-04-19 | 南京日光生物科技有限公司 | A kind of backbone patch and preparation method thereof with far infrared heating layer |
| CN110038077A (en) * | 2019-05-31 | 2019-07-23 | 王亮 | A kind of plaster for treating osteoproliferation, spur |
| CN110882373A (en) * | 2019-12-10 | 2020-03-17 | 刘维来 | A Chinese medicinal preparation for external use for treating various osteopathia |
| CN112168684A (en) * | 2020-10-28 | 2021-01-05 | 王秀琴 | Moxa cone for treating cyst, nodule, hyperplasia and tumor and preparation method thereof |
| CN112603957A (en) * | 2021-01-11 | 2021-04-06 | 谭秀波 | Traditional Chinese medicine for treating hyperosteogeny and preparation method thereof |
| CN114272226A (en) * | 2021-12-29 | 2022-04-05 | 贵州德良方药业股份有限公司 | External plaster for treating hyperosteogeny and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102266541B (en) | 2012-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102266541B (en) | Chinese medicinal plaster for treating hyperosteogeny or hyperosteogeny pain | |
| CN101411802B (en) | Black plaster for treating hyperosteogeny and preparation method thereof | |
| CN100376276C (en) | Soothe tendons and activating-blood anodyne plaster | |
| CN102488869B (en) | Traditional Chinese medicinal external-use liniment for muscle and bone ache | |
| CN100488549C (en) | Externally applied medicament for treating rheumatism | |
| CN103316308A (en) | Traditional Chinese medical liquor for external use | |
| CN102836177B (en) | Traditional Chinese medicine preparation for treating osteopathia | |
| CN101843873B (en) | Muscle-nourishing bone-strengthening ointment | |
| CN103599494A (en) | Externally applied traditional Chinese medicine for treatment of cervical spondylosis | |
| CN104288538A (en) | Plaster for treating neck, shoulder, waist and leg diseases and preparation method of plaster | |
| CN103463349A (en) | Traditional Chinese medicine composition for treating acute lumbar sprain | |
| CN101234153B (en) | Externally-applied medicament for treating bone fracture | |
| CN102961483B (en) | Traditional Chinese medicine composition for treating pain in waist and lower extremities and preparation method thereof | |
| CN105233145A (en) | Musk medicine for dispelling wind | |
| CN101164610A (en) | Blood-circulation and removing blood stasis ointment | |
| CN102949680B (en) | Medicinal liquor for treating cervical spondylosis and preparation method thereof | |
| CN103386053A (en) | Externally applied medicinal liquor for curing pain | |
| CN103356953B (en) | A kind of Chinese medicine composition for the treatment of lumbar muscle strain | |
| CN101766729B (en) | Damp-clearing pain-relieving liquor and acupoint application treatment method | |
| CN101874884B (en) | Joint pain-relieving plaster | |
| CN101061975A (en) | Medicine mat for preventing and treating cervical vertebrae diseases | |
| CN102949507B (en) | Traditional Chinese medicine lotion for treating lumbocrural pain and preparation method thereof | |
| CN102579725A (en) | Chinese medicine for heel physiotherapy | |
| CN105497824A (en) | Traditional Chinese medicine composition for treating calcaneodynia | |
| CN103656001A (en) | Compound medicine for treating osteoproliferation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121226 Termination date: 20130711 |